Literature DB >> 8530888

[Effects of prostaglandin E2 and sodium hyaluronate on bradykinin induced knee joint pain in rat].

I Yamashita1, Y Atsuta, S Shimazaki, M Miyatsu.   

Abstract

We studied effects of prostaglandin E2 and sodium hyaluronate on the reactive muscle activity induced by intra-articular injection of bradykinin into the knee joint of rat. An animal model was developed to evaluate knee joint pain. In unanesthetized and spinalized rat, bradykinin (BK) was injected into the knee joint and the duration of the reactive activity of the knee flexor was evaluated. The duration of the reaction was elongated dependent on the injected BK dosage (0.025-2.5 micrograms). When prostaglandin E2 (PG E2) was injected with BK, the duration of the reaction increased significantly (p < 0.01). In contrast, sodium hyaluronate (Na-HA: average MW 900 kD) injected into the joint 3-24 hours in advance significantly inhibited the BK induced reaction (p < 0.05-0.01). A histological study demonstrated the fluorescein-labeled Na-HA diffusely infiltrating into the surface of the soft tissue. From these results, the animal model used in the present study was valuable to evaluate quantitatively knee joint pain. Furthermore, the sensitizing effect of PG E2 and the inhibitory effect of Na-HA on joint pain was objectively demonstrated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530888

Source DB:  PubMed          Journal:  Nihon Seikeigeka Gakkai Zasshi        ISSN: 0021-5325


  2 in total

1.  Cartilage degeneration is associated with augmented chemically-induced joint pain in rats: a pilot study.

Authors:  Meguru Okamoto; Yuji Atsuta
Journal:  Clin Orthop Relat Res       Date:  2009-12-15       Impact factor: 4.176

2.  Cyclooxygenase-2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees.

Authors:  Junya Ozawa; Akinori Kaneguchi; Ryo Tanaka; Nobuhiro Kito; Hideki Moriyama
Journal:  BMC Musculoskelet Disord       Date:  2016-10-24       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.